Kyau mafi kyau don Ka gwada
Idan kana da ciwo mai cututtuka na al'ada ( COPD ) ko san wanda ya yi, ba shakka ba za ka yi mamakin sanin cewa rashin tausayi da damuwa ba ne sakamakon cutar wannan cuta mai rikici. Aikin binciken da aka buga a jaridar Thorax a 2010, alal misali, mutanen da ke tare da COPD sune kashi 85 cikin dari na iya haifar da mummunan rikici fiye da sauran mutane.
Hakazalika, a cikin nazarin 2011 na fiye da mutane 2,000, kashi 26 cikin 100 na wadanda ke tare da COPD sun sha wahala, yayin da aka kwatanta da kashi 12 cikin dari na batutuwa da suka kyauta amma ba su da COPD da kashi 7 cikin wadanda ba su halarta ba tare da COPD ba.
Mene ne ƙarin, damuwa da damuwa a tare da COPD na iya haifar da zagaye mai banƙyama: Idan kana da COPD kuma yana gwagwarmayar numfashi, za ka iya fara tsoro-amma jin tsoro yana iya tsoma baki tare da numfashi. A gaskiya ma, marasa lafiya na COPD sau goma ne da dama fiye da mutane ba tare da yanayin da zasu fuskanci hare-haren tsoro da tsoro ba.
1 -
Shari'ar ta magance magungunan maganin rashin jin tsoroMagunguna masu rikitarwa irin su Xanax (alprazolam) da Valium (diazepam) basu da manufa ga mutanen da ke tare da COPD saboda waɗannan kwayoyi sun rage jinkirin numfashi. Duk da haka, wasu magunguna da wadanda ba a miyagun ƙwayoyi ba zasu iya taimakawa tare da damuwa da damuwa kuma suna da daraja magana da likitanka.
Kara
2 -
Abun ciki a kan mafi kyawun magungunaAkwai hanyoyi da yawa na antidepressant samuwa don magance bakin ciki. Dukansu tsofaffin ɗalibai, masu tricyclics, da kuma na biyu mafi tsohuwar ajiya, masu hana magunguna guda daya (MAOI) sunyi nazari a cikin mutanen da ke tare da COPD amma ba a nuna musu ba.
Haka yake daidai da sababbin magungunan antidepressants-masu sukar maganin serotonin mai sa maye gurbin, ko SSRIs. Duk da haka, ana ganin SSRIs mafi kyau fiye da magungunan tsofaffin kwayoyi don magance bakin ciki ko damuwa da alaka da COPD. Suna aiki ta hanyar hana reuptake (rebsonption) na nerotransmitter serotonin ta hanyar kwayar cutar da ke ɓoye shi. Wannan hanyar, za a iya samun sifa a cikin kwakwalwa. Ƙananan matakan serotonin an danganta su da damuwa da damuwa. SSRI sun hada da Prozac (fluoxetine), Zoloft (sertraline), Lexapro (escitalopram), da Paxil (paroxetine).
Wadanda ba za su fada cikin kowane nau'i na sama ba, irin su Wellbutrin (bupropion), Serzone (nefazodone), da Remeron (mirtazapine), ba a yi nazari sosai a cikin mutane tare da COPD ba.
3 -
Ƙwararren ƙwararren ƙwararruIdan kun kasance kamar mutane da yawa tare da COPD, za ku ji jin dadin jin dadin zuciya ko damuwa tare da maganin halayyar halayyar zuciya (CBT) maimakon shan magani. CBT wani tsari ne wanda aka tsara da shi wanda yake koya maka ka canza yadda kake tunani ko jin dadi game da yanayin da ba za ka iya yin kome ba game da.
CBT zai iya zama hanya mai mahimmanci wajen magance dukan batutuwan da suka danganci bakin ciki ko damuwa da COPD ke haifarwa, kullum yana aiki sosai da sauri, kuma baya sanya ku cikin hadarin maganin magani na jiki. Kwararka zai iya mayar da kai ga likitan ilimin psychologist ko sauran masu kiwon lafiya na tunanin mutum wanda zai iya ba ka CBT.
Sources:
Eisner, Mark D., et. al. "Rashin Damuwa da Harkokin Kiwon lafiya a COPD." Thorax . Mar 2010; 65 (3): 229-234.
Fritzsche, A., et al. "Hanyoyin Magungunan Kwayoyi da Nazarin Harkokin Lafiya a cikin marasa lafiya tare da COPD-A Review." Magunguna na numfashi . Oct 201; 105 (10): 1422-1433.
Panagioti, M., et al. "Bayani game da Labaran Lafiya, Impact, da Gudanarwa na Rashin hankali da kuma damuwa a Lafiya na Ciwon Gwagwarmaya." Wallafe-wallafe na kasa da kasa na cutar cututtuka . Nov 2014 > 13; 9: 1289-306.
Usmani, ZA, et al. "Harkokin Kiwon Lafiya na Pharmacological don magance cututtuka da bala'i a cikin ƙananan cututtuka na ƙwayar cuta." Cochrane Database of Manyan Labarai . Nov 9, 2011; (11): CD008483.
Yohannes, AM, et al. "Magungunan Pharmacological Treatment of Depression a cikin Tsofaffin Marasa lafiya tare da Kwayoyin cuta na Ciwon Gwagwarmaya Cutar: Imfani da cutar da sakamakon Lafiya." Drugs da tsufa . Yuli 2014; 31 (7): 483-492.